Harlem Hospital Center, branded as NYC Health + Hospitals/Harlem, is a 272-bed, public teaching hospital affiliated with Columbia University. It is located at 506 Lenox Avenue in Harlem, Manhattan, New York City and was founded in 1887.

There are 272 beds in Harlem Hosp Ctr.

During the past decade, Harlem Hosp Ctr conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 6 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 4 clinical trials were completed. i.e. 44.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Harlem Hosp Ctr" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 56 trials, followed by "Centers for Disease Control and Prevention" with 11 trials sponsored, "Glaxo Wellcome" with 3 trials sponsored, "Pfizer" with 3 trials sponsored and "Icahn School of Medicine at Mount Sinai" with 3 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Harlem Hosp Ctr" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 27 trials as a collaborator, "US Department of Veterans Affairs" with 9 trials as a collaborator, "Glaxo Wellcome" with 8 trials as a collaborator, "Bristol-Myers Squibb" with 6 trials as a collaborator and "Agency for Healthcare Research and Quality (AHRQ)" with 1 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Harlem Hosp Ctr" are "HIV Infections" (66 trials), "Tuberculosis" (9 trials), "COVID-19" (3 trials), "Pneumonia, Pneumocystis Carinii" (3 trials) and "HIV Seronegativity" (2 trials). Many other conditions were trialed in "Harlem Hosp Ctr" in a lesser frequency.

Most popular intervention types in "Harlem Hosp Ctr" are "Drug" (63 trials), "Biological" (11 trials), "Behavioral" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Zidovudine" (19 trials), "Didanosine" (12 trials), "Ritonavir" (12 trials), "Stavudine" (9 trials) and "Lamivudine" (8 trials). Other intervention names were less common.

The vast majority of trials in "Harlem Hosp Ctr" are 85 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Harlem Hosp Ctr". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 77 completed trials in Harlem Hosp Ctr, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Harlem Hosp Ctr, 20 "Phase 1" clinical trials were conducted, 27 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 14 trials that are defined as “Not Applicable".